4//SEC Filing
Humphries William D. 4
Accession 0001169245-23-000031
CIK 0001169245other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:18 PM ET
Size
7.1 KB
Accession
0001169245-23-000031
Insider Transaction Report
Form 4
Humphries William D.
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-19+2,538→ 2,538 total - Exercise/Conversion
Restricted Stock Units
2023-05-19−2,538→ 0 total→ Common Stock (2,538 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
- [F2]The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001674278
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:18 PM ET
- Size
- 7.1 KB